Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Viens

Showing results (141-150 of 244) with videos related to

Pageof 25
Sort By:
Bulletin Du Cancer|March 1, 1997
[Adjuvant chemotherapy with mitoxantrone, cyclophosphamide and 5-fluorouracil in breast neoplasms: therapeutic life]D Genre, G Macquart-Moulin, M L Bouscary, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
British Journal of Cancer|January 1, 1997
Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of careG Macquart-Moulin, P Viens, M L Bouscary, et al.
Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation|August 1, 1992
Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infectionsD Blaise, A M Stoppa, P Viens, et al.
Bone Marrow Transplantation|July 1, 1995
Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantationR Costello, D Blaise, J Jacquemier, et al.
Bulletin Du Cancer|August 1, 1996
[Contamination of cytapheresis by tumor cells: apropos of 39 breast cancer cases]M J Mozziconacci, C Arnoulet, G Novakovitch, et al.
Bone Marrow Transplantation|July 20, 2002
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsJ-O Bay, J Fleury, B Choufi, et al.
Oncology Reports|April 18, 2000
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclinM P Mathoulin-Portier, P Viens, D Cowen, et al.
Public Health Genomics|April 11, 2013
Breast cancer patients' views on the use of genomic testing to guide decisions about their postoperative chemotherapyV Seror, P Marino, F Bertucci, et al.
Pageof 25

Showing results (141-150 of 244) with videos related to

Sort By:
Pageof 25
Bulletin Du Cancer|March 1, 1997
[Adjuvant chemotherapy with mitoxantrone, cyclophosphamide and 5-fluorouracil in breast neoplasms: therapeutic life]D Genre, G Macquart-Moulin, M L Bouscary, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot studyA Ibrahim, E Zambon, J H Bourhis, et al.
British Journal of Cancer|January 1, 1997
Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of careG Macquart-Moulin, P Viens, M L Bouscary, et al.
Blood|November 1, 1991
High-dose recombinant interleukin-2 and acute myeloid leukemias in relapseD Maraninchi, D Blaise, P Viens, et al.
Bone Marrow Transplantation|August 1, 1992
Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infectionsD Blaise, A M Stoppa, P Viens, et al.
Bone Marrow Transplantation|July 1, 1995
Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantationR Costello, D Blaise, J Jacquemier, et al.
Bulletin Du Cancer|August 1, 1996
[Contamination of cytapheresis by tumor cells: apropos of 39 breast cancer cases]M J Mozziconacci, C Arnoulet, G Novakovitch, et al.
Bone Marrow Transplantation|July 20, 2002
Allogeneic hematopoietic stem cell transplantation in ovarian carcinoma: results of five patientsJ-O Bay, J Fleury, B Choufi, et al.
Oncology Reports|April 18, 2000
Prognostic value of simultaneous expression of p21 and mdm2 in breast carcinomas treated by adjuvant chemotherapy with antracyclinM P Mathoulin-Portier, P Viens, D Cowen, et al.
Public Health Genomics|April 11, 2013
Breast cancer patients' views on the use of genomic testing to guide decisions about their postoperative chemotherapyV Seror, P Marino, F Bertucci, et al.
Pageof 25